PreprintAll rights reservedbioRxiv
Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
- 1INSERM U955
Related
- A knockout screening platform for interferon-stimulated genes in respiratory cells identifies LY6E as a dominant antiviral effector against coronaviruses
- Structural mechanism of TRPC3 inhibition by a potent antagonist
- A bivalent oral vaccine against Micropterus salmoides rhabdovirus and largemouth bass ranavirus based on yeast surface display technology
- A mutation-agnostic and allele-specific ASO strategy demonstrates potent functional rescue and retinal preservation in RHO-linked retinitis pigmentosa
- Discovery of potent anti-inflammatory flavonoid-sesquiterpenoid hybrids from Syzygium simile: Structure–activity relationships and nanomolar inhibition of human neutrophil activation
BibTeX
@misc{molina2026bivalent,
title = {{Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses}},
author = {D. Salomon Lopez Molina and N. Ahnou and R. Brillet and J.-G. Delcros and L. Softic and B. Jimenez Araya and M. Duval and M. Veruete and A. Bancet and D. Grenier and A. Mularoni and J.-M. Pawlotsky and I. Krimm and A. Ahmed-Belkacem},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.05.756735},
url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756735v1},
}
RIS
TY - UNPB
TI - Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
AU - D. Salomon Lopez Molina
AU - N. Ahnou
AU - R. Brillet
AU - J.-G. Delcros
AU - L. Softic
AU - B. Jimenez Araya
AU - M. Duval
AU - M. Veruete
AU - A. Bancet
AU - D. Grenier
AU - A. Mularoni
AU - J.-M. Pawlotsky
AU - I. Krimm
AU - A. Ahmed-Belkacem
PY - 2026
DA - 2026/10/05
PB - bioRxiv
DO - 10.64898/2026.10.05.756735
UR - https://www.biorxiv.org/content/10.64898/2026.10.05.756735v1
ER -